CDNA Debt to Equity
0.05×TTM
Retrieved:
CDNA FY Debt/Equity
2.04×-6.37×
2012-12-312025-12-31
Source: Financial Modeling Prep (FMP). Annual fiscal periods. Dates are period ends; a fiscal year may differ from a calendar year.
CDNA debt to equity history
Debt-to-equity ratio. The available annual fiscal periods series contains 14 observations from Dec 31, 2012 to Dec 31, 2025.
| Period ending | Debt to Equity |
|---|---|
| 0.0864× | |
| 0.075× | |
| 0.131× | |
| 0.0905× | |
| 0.0458× | |
| 0.0652× | |
| 0.0544× | |
| 0.0018× | |
| -5.5525× | |
| 1.229× | |
| 0.5341× | |
| 0.2763× | |
| -0.1023× | |
| -0.1014× |
Compare debt to equity
Other companies in Health Care. Each page shows its own reporting periods and currency.
- Guardant Health Inc (GH) debt to equity
- Bridgebio Pharma Inc (BBIO) debt to equity
- Brightspring Health Services Inc (BTSG) debt to equity
- Madrigal Pharmaceuticals Inc (MDGL) debt to equity
- Ensign Group Inc (ENSG) debt to equity
- Glaukos Corp (GKOS) debt to equity
- Vaxcyte Inc (PCVX) debt to equity
- Krystal Biotech Inc (KRYS) debt to equity
Compare all covered stocks by debt to equity →
All CDNA financial metrics · CDNA stock overview · How to interpret financial metrics